SCHEMBL3830664

SCHEMBL3830664

COc1ccc2cnc(-c3ccccc3)cc2c1

nearest known ligand 0.91

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 8/20 0.91
RAB9A P51151 7/20 0.91
CASP3 P42574 2/20 0.73
SENP7 Q9BQF6 2/20 0.73
CYP11B2 P19099 2/20 0.55
CYP11B1 P15538 1/20 0.55
IDO1 P14902 3/20 0.55
TDO2 P48775 3/20 0.55
CYP1A2 P05177 1/20 0.52
CYP2A6 P11509 1/20 0.52
KDM4E B2RXH2 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
CYP17A1 P05093 1/20 0.50
DYRK1A Q13627 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14102879 0.95 NPC1 (1.00) NPC1RAB9ACASP3SENP7CYP11B2
SCHEMBL12463736 0.86 NPC1 (0.71) NPC1RAB9ACASP3SENP7CYP11B2
SCHEMBL2428152 0.85 NPC1 (1.00) NPC1RAB9ACASP3SENP7CYP11B2
SCHEMBL312142 0.85 NPC1 (1.00) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL30179137 0.85 NPC1 (1.00) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL3825612 0.82 RAB9A (0.71) NPC1RAB9ACASP3SENP7CYP1A2
SCHEMBL29493150 0.80 NPC1 (0.67) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL29838915 0.80 NPC1 (0.67) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL729768 0.80 NPC1 (0.67) NPC1RAB9ACASP3SENP7IDO1
SCHEMBL3825604 0.80 NPC1 (0.68) NPC1RAB9ACASP3SENP7IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2099765-A2 5, 6, OR 7-SUBSTITUTED-3-(HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS Rexahn Pharmaceuticals, Inc. (US) 2009-09-16 EP disclosed
WO-2008063548-A2 5, 6, OR 7-SUBSTITUTED-S- (HETERO)ARYLISOQUINOLINAMINE DERIVATIVES AS ANTITUMOR AGENTS REXAHN PHARMACEUTICALS, INC. (US) 2008-05-29 WO disclosed